Announcements Trials
Browse Landscape

Phase

Phase 2 8Phase NA 6Phase 3 3Phase EARLY_PHASE1 2Phase 4 1Phase 2/3 1

Status

Completed 31Unknown 26Recruiting 19Terminated 9Not yet recruiting 5Active not recruiting 3Suspended 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 2Gastrointestinal 1

Conditions

Esophageal Neoplasms 1Carcinoma, Intraductal, Noninfiltrating 1Breast Neoplasms 1Adenocarcinoma Of Esophagus 1Adenocarcinoma 1

Interventions

Carboplatin 108Cisplatin 98Paclitaxel 79pembrolizumab 70Gemcitabine 60Pemetrexed 49Cyclophosphamide 48Dexamethasone 47Docetaxel 46durvalumab 44Capecitabine 44Radiotherapy 42Doxorubicin 40Lenalidomide 38Specimen Handling 37Nivolumab 37Oxaliplatin 35Rituximab 34Magnetic Resonance Spectroscopy 33Fluorouracil 33Etoposide 32Bevacizumab 32Vincristine 30atezolizumab 29Radiation 28Leucovorin 28Bortezomib 26Prednisone 23Letrozole 23Fulvestrant 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Active not recruiting × Neoadjuvant Therapy × Clear all
NCT01272037 2026-05-26

Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer

National Cancer Institute (NCI)

Phase 3 Active not recruiting
5,018 enrolled 14 charts
Breast

Carcinoma, Intraductal, Noninfiltrating

NCT02089100 2026-03-19

STEREO-SEIN

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Active not recruiting
154 enrolled
Breast

Breast Neoplasms

NCT02509286 2024-05-08

ESOPEC

University Hospital Schleswig-Holstein

Phase 3 Active not recruiting
438 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Adenocarcinoma, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡